The CCNE1 gene helps control the cell cycle, the timed steps cells use to copy their DNA and divide. If it does not work normally, or if cells carry extra copies of it, cell growth can become less controlled. In medicine, this gene is important because unusually high CCNE1 activity is linked to several cancers, especially ovarian cancer and sometimes uterine, bladder, and stomach cancers. CCNE1 is mainly known in cancer research rather than in everyday public discussion.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or guiding activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly regulate when a process happens, where it takes place, and how active it is. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
CCNE1Gene function
What if the gene works
The CCNE1 gene helps control when cells copy their DNA and begin dividing. Its protein works with a partner protein to move cells into the next step of the cell cycle at the right time.
Risk
What if the gene does not work
Changes in the CCNE1 gene can range from milder to more severe and may disrupt how cells move from growth into DNA copying. When CCNE1 works poorly, this cell cycle timing becomes less controlled, which can alter normal cell division.
Treatment
What does that mean for your treatment
No CCNE1-specific treatment or drug selection approach is currently established for pathogenic or loss-of-function variants in the CCNE1 gene. In cancer research, altered CCNE1 activity is being studied as a biomarker and possible treatment target, including with drugs aimed at CDK2 and related cell cycle pathways.
Gene function
What if the gene works
Your body uses the CCNE1 gene to help cells move through a key checkpoint before they divide. Its protein, cyclin E1, acts like a timed signal that helps a cell begin copying its DNA at the right moment. Understanding the CCNE1 gene's function helps show how tissues grow, renew, and heal in an orderly way.
The CCNE1 gene helps set the pace as a cell gets ready to divide. Its protein joins with CDK2, a partner protein, to move the cell from growth into the stage where DNA copying begins.
Inside your cells, the CCNE1 gene helps switch on the early steps needed to copy DNA. This supports an orderly start to the cell cycle stage when each chromosome is duplicated.
Cyclin E1 rises for a short window, giving cells a timed signal rather than a constant push to divide. That brief burst helps growth, DNA copying, and division stay in the right order.
What is a variant?
Within a gene, a genetic variant is a small change in the DNA sequence. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some CCNE1 gene variants, including extra gene copies, can lead to too much cyclin E1 protein, protein that lasts longer than usual, or altered binding to partner proteins, which can push cells through the growth cycle at the wrong time. More disruptive variants may sharply reduce protein production or make the protein unstable, while milder variants may only partly change activity. This range helps explain how CCNE1 gene variants affect cell cycle control at the molecular level.
How variants are linked to conditions
CCNE1 does not yet have a broadly confirmed link to a specific inherited health condition, although research on CCNE1 gene variants and disease is still developing. If you have a confirmed change in the CCNE1 gene, your doctor or genetic counselor can explain what it may mean in the context of your own health and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are also involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCNE1 gene itself. If CCNE1 is part of your test results and you are concerned about what it means for your personal or family risk, speaking with a doctor or genetic counselor can help put it in context.
Inheritance of CCNE1 variants
For people looking into how CCNE1 variants are inherited, there is not yet a broadly confirmed disease-specific Mendelian inheritance pattern for the CCNE1 gene. Most well-known CCNE1 changes are discussed in the context of tumor testing rather than a clearly established inherited genetic condition. The CCNE1 gene is located on chromosome 19, which is an autosome, so each person inherits one copy from each parent.
What does my CCNE1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for the CCNE1 gene, though this can change as research moves forward. If you have a specific CCNE1 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
CCNE1 genetic testing usually analyzes DNA from blood, saliva, or sometimes a tumor sample. Labs use DNA sequencing to look for small variants and copy number testing to see whether extra copies of the CCNE1 gene are present. Your results report states whether an important change was found.
When should I consider getting a genetic test?
There is not yet a broadly established, CCNE1-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and the advice of a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it can tell you depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but not as well for another. These inherited differences are common and can influence both how well a medicine works and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CCNE1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. CCNE1 is being studied in some cancers, where extra copies of the gene in a tumor may affect how well certain targeted treatments work, but this remains a specialist research area rather than routine prescribing.
History
The CCNE1 gene entered cancer research as scientists worked out how human cells move through the growth cycle. In the early 1990s, researchers identified cyclin E as a key timing signal for the step just before a cell copies its DNA. Building on this early work, scientists uncovered more about the gene when extra copies and unusually high activity were found in several cancers, especially ovarian and uterine cancers. These findings helped connect basic cell cycle research with real tumor behavior in the clinic. Over time, descriptions became more precise as CCNE1 became recognized as part of a broader group of genes that can drive cancer when cell growth control is lost. Today, its history is closely tied to the modern understanding of how disrupted cell timing contributes to cancer.